Literature DB >> 20684716

Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs.

Carl D Kirkwood1.   

Abstract

The successful development and implementation of rotavirus vaccines will have a significant impact on rotavirus-induced gastroenteritis in children worldwide. However, this introduction will increase the immune pressure against wild-type rotavirus strains circulating in the community, altering the forces and balances that drive rotavirus evolution. There is concern that antigenically distinct novel or rare strains may be selected and spread, decreasing vaccine efficacy. This review describes the diversity of rotavirus strains and the mechanism by which wild-type rotavirus strains can evolve, including genetic drift and genetic reassortment.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20684716     DOI： 10.1086/653548

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  50 in total

Review 1.  Rotavirus diversity and evolution in the post-vaccine world.

Authors:  John T Patton
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

2.  Evidence of VP7 and VP4 intra-lineage diversification in G4P[8] Italian human rotaviruses.

Authors:  Maria Cristina Medici; Fabio Tummolo; Paola Guerra; Maria Cristina Arcangeletti; Carlo Chezzi; Flora De Conto; Adriana Calderaro
Journal:  Virus Genes       Date:  2013-12-19       Impact factor: 2.332

3.  Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain.

Authors:  Olga Redondo; Rosa Cano; Lorena Simón
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea.

Authors:  Nonkululeko B Magagula; Mathew D Esona; Martin M Nyaga; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Mapaseka L Seheri; A Duncan Steele; David E Wentworth; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2014-05-20       Impact factor: 2.327

5.  Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.

Authors:  Khadijeh Nasiri; Mohammadreza Nassiri; Mojtaba Tahmoorespur; Alireza Haghparast; Saeed Zibaee
Journal:  Adv Pharm Bull       Date:  2016-03-17

Review 6.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

7.  Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Abdul Rauf; Stephanie N Langel; David E Wentworth; Karla M Stucker; Rebecca A Halpin; Ham Ching Lam; Douglas Marthaler; Linda J Saif; Anastasia N Vlasova
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

8.  Full-length genome analysis of the first human G8P[14] rotavirus strain from Morocco suggests evidence of zoonotic transmission.

Authors:  Sanaâ Alaoui Amine; Marouane Melloul; Moulay Abdelaziz El Alaoui; Nadia Touil; Elmostafa El Fahime
Journal:  Virus Genes       Date:  2019-06-13       Impact factor: 2.332

9.  Full-genome characterization of a G8P[8] rotavirus that emerged among children with diarrhea in Croatia in 2006.

Authors:  Roberto Delogu; Alessandra Lo Presti; Franco Maria Ruggeri; Eleonora Cella; Marta Giovanetti; Massimo Ciccozzi; Suncanica Ljubin-Sternak; Suzana Bukovski-Simonoski; Amarela Lukic-Grlic; Giovanni Ianiro; Lucia Fiore
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

10.  Investigation of Rotavirus with Various Methods in Children with Acute Gastroenteritis and Determination of Its Molecular Epidemiology in Kayseri Province, Turkey.

Authors:  Sukran Artiran; Altay Atalay; Selma Gökahmetoglu; Mehmet Adnan Ozturk; Nurgul Balci; Nuri Cakir; Huseyin Kilic; Riza Durmaz
Journal:  J Clin Lab Anal       Date:  2016-07-25       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.